Vapers are susceptible to infection by SARS-CoV-2, the virus that spreads COVID-19 and continues to infect people around the world, a University of California, Riverside, study has found.
Apellis trims staff, shrinks R&D plans to save money in face of looming competition in ophthalmology
Apellis Pharmaceuticals is in cash-saving mode as it looks to ward off a newly-minted competitor in treating a leading cause of blindness. The drugmaker said